q4 earnings - Search News

BIO Q4 Earnings and Revenues Miss Estimates

$200 in Sight for Philip Morris Stock Following Combustive Q4 Earnings Results

Tobacco seller Philip Morris International (PM) recently soared to new heights on the back of its blockbuster Q4 2024 earnings results, thereby

Zacks.com on MSN · 14h

BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket

Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.90, which missed the Zacks Consensus Estimate of $2.93 by 1.0%. The bottom line decreased 6.4% from the prior-year quarter’s level.

Investing.com on MSN · 1d

Earnings call transcript: Bio-Rad Q4 2024 results miss forecasts

Bio-Rad Laboratories Inc (NYSE:BIO). reported its fourth-quarter 2024 earnings, revealing a slight miss on revenue expectations, with net sales of $668 million compared to a forecast of $681.29 million.

Q4 Earnings Snapshot

The Washington Post · 1d

CyberArk: Q4 Earnings Snapshot

PETACH-TIKVA, Israel — PETACH-TIKVA, Israel — CyberArk Software Ltd. (CYBR) on Thursday reported a loss of $97.1 million in its fourth quarter. The Petach-Tikva, Israel-based company said it had a loss of $2.02 per share. Earnings, adjusted for one-time gains and costs, came to 80 cents per share.

Houston Chronicle · 21h

AMC Networks: Q4 Earnings Snapshot

The owner of cable channels including AMC and IFC posted revenue of $599.3 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected

Zacks.com on MSN · 19h

AMC Networks (AMCX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

AMC Networks (AMCX) reported $599.31 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 11.7%. EPS of $0.64 for the same period compares to $0.72 a year ago.

US fourth-quarter 2024 earnings growth set to be highest in three years

S&P 500 earnings growth for the fourth quarter of 2024 is on track to be the highest since the end of 2021, according to LSEG ...

Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

Zacks Investment Research on MSN19h

SolarEdge Technologies to Report Q4 Earnings: What's in the Cards?

SolarEdge Technologies, Inc. SEDG is scheduled to release fourth-quarter 2024 results on Feb. 19, before market open. Find ...

1don MSN

Roku Q4 Revenue Climbs 22%, Streaming Households Hit Nearly 90 Million as Earnings Beat Expectations

Roku overdelivered for the fourth quarter of 2024, boosting revenue 22% and narrowing its net loss to beat Wall Street ...

The Motley Fool on MSN1d

Alnylam Delivers a Big Q4 Earnings Beat

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

Zacks Investment Research on MSN17h

Flowserve Set to Report Q4 Earnings: What's in the Offing?

Flowserve Corporation FLS is slated to release fourth-quarter 2024 results on Feb. 18, after market close. The Zacks ...

Reddit Tanks After Q4 Earnings: Why I'm Doubling Down

Reddit's Q4 earnings showed strong growth and profitability, but user growth fell short of analyst expectations, leading to a ...

Commercial Observer1d

CBRE Reports Record Earnings With Q4 Revenues of $10B, Cash Flow Up 60%

CBRE reported improved financials across all metrics during its fourth-quarter earnings call Thursday, driven by strong ...

Crocs Smashes Q4 Earnings Expectations Amid Accelerated China Growth; Stock Jumps

Crocs exceeds Q4 earnings expectations, driven by strong China growth, while HEYDUDE faces challenges, sending shares up.

17h

Moderna (MRNA) Q4 2024 Earnings Call Transcript

Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

Tariffs, AI And A Strong Dollar Drive Key S&P 500 Q4 Earnings Trends

The market is paying particularly close attention to Q4 earnings, given the S&P 500’s lofty valuation. Potential tariffs and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results